3 Major Studies dropped on the same Day, opening a new Health Frontier against Cancer
Physionic
Apr 9, 2026
Episode description
JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]
Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2
HEALTH AUTONOMY [COURSE]
Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomy
JOIN THE COMMUNITY
Join my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2
EMAIL LIST
1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6
HIRE ME FOR CONSULTING:
Consulting: https://bit.ly/3dmUl2H
Created with Biorender
Fiber on Cancer Risk: https://www.youtube.com/watch?v=mZOCHKgsjCA
Short Chain Fats and Immune Function: https://www.youtube.com/watch?v=7Cf2_PtTaqA
0:00 - Introduction
0:48 - The Problem of Cancer Evasion
2:28 - The Answer is in the Billions
4:04 - A Dysregulated Immune System
5:17 - Speaking in Broad Strokes, What to Do?
References*
**Full Funding/Conflicts are provided in the free article (found in email list and Physionic Community Article Library)
[Study 700] Elkrief A, et al. Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial. Nat Med. 2026. doi:10.1038/s41591-025-04186-5.
Funding/Conflict: Funded by public and non-profit grants in Canada and Europe; no trial-specific industry funding reported. Several authors disclosed pharma research support, consulting/honoraria, company co-founding roles, and patents; others reported no conflicts.
[Study 701] Porcari S, et al. Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial. Nat Med. 2026. doi:10.1038/s41591-025-04189-2.
Funding/Conflict: Funded by public and non-profit agencies in Italy, Europe, France, and the US; no industry funding reported. A minority of authors disclosed speaking/consulting/advisory fees, company interests, and patents; others reported no conflicts.
[Study 702] Fernandes R, Jabbarizadeh B, Rajeh A, et al. Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial. Nat Med. 2026. doi:10.1038/s41591-025-04183-8.
Funding/Conflict: Funded by public grants and philanthropic/non-profit support in Canada; no trial-specific industry funding reported. A few authors disclosed company co-founding roles, patents, outside grants, and pharma advisory/consulting relationships; all others reported no conflicts.
Please use the following link to submit your critique: https://bit.ly/PhysionicCritique
Disclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes.
Mindsip insights from this episode:
Deactivate cancer's immune evasion with PD-L1 insights
Successful cancer cells can deactivate your immune system's T-cells by using a protein called PD-L1 to engage with the T-cell's PD-1 receptor.
Purge harmful microbes for effective microbiome therapy
The majority of the benefit from microbiome therapy in recent cancer studies came from purging the gut of harmful microbes, rather than adding new ones.
Reevaluate microbiome diversity's role in cancer outcomes
Contrary to popular belief, greater microbiome diversity was not consistently the most important factor for better cancer outcomes in recent studies.
Focus on prebiotics and short-chain fatty acids for microbiome health
Until microbiome pills are widely available, researchers from the studies suggest focusing on prebiotics like fiber and possibly supplementing with short-chain fatty acids.
Enhance gut health to boost natural killer cells
An improved microbiome can lead to a resurgence of powerful cancer-killing immune cells, particularly the Natural Killer (NK) cell.
Utilize cancer-fighting microbiome pills for improved survival rates
In recent clinical trials, cancer patients who took pills containing the microbiome from healthy donors showed dramatically improved survival rates.
Utilize bacteriophages to target and alter microbiome
An innovative future approach to altering the microbiome could involve using bacteriophages, which are viruses that specifically target and kill certain bacteria.
More from
Physionic
You also might be interested in
Are “Poop Pills” The Ultimate Bowel Biohack Of The Future? The Science of Fecal Microbiota Transplants (FMT) with Jason Klop.
"Oil Changes" For Your Blood, DIRTY Pharmaceutical Secrets, AI-Powered Medicine & More With Brigham Buhler.
I Injected Stem Cells Into My Penis (Here's What Happened)
The AMAZING Future Of Regenerative Medicine, The New Sexier Alternative To Stem Cells, Where You Should Get Peptides (& The Best Peptides Stacks) & More With Dr. Matt Cook
Avoiding, Treating & Curing Cancer | Dr. Alex Marson
